Statistics for CONMED (id:9241 CNMD)

Valuation metrics

Market cap

2.31B

Enterprise value

3.21B

Trailing P/E (ttm)

17.72

Forward P/E

15.45

PEG ratio

15.45

Price/Sales (ttm)

1.79

Price/Book (mrq)

2.48

Enterprise Value/Revenue

2.50

Enterprise Value/EBITDA

14.76

Overview

Shares outstanding

30.89M

Float

30.61M

Shares short

2.46M

% Held by insiders

0.01%

% Held by institutions

1.20%

Average volume (10 days)

549.34K

Average volume (90 days)

Price summary

52-Week low

61.05

52-Week high

117.27

52-Week change

-54.12%

Beta

1.46

50-Day moving average

69.66

200-Day moving average

73.27

Dividends and splits

Forward annual dividend rate

0.80

Forward annual dividend yield

0.01

Trailing annual dividend rate

0.80%

Trailing annual dividend yield

0.01

5-Year annual dividend yield

0.82

Payout ratio

0.19

Dividend date

October 04th, 2024

Ex-dividend date

September 16th, 2024

Last split factor

2:1

Last split date

September 10th, 2001

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

10.23%

Operating margin

12.22%

Operational effectiveness

Return on assets

3.98%

Return on equity

15.24%

Income statement

Revenue (ttm)

41.82

Revenue per share (ttm)

41.82

Quarterly revenue growth (yoy)

2.09

Gross profit (ttm)

676.24M

EBITDA

269.87M

Net income to common (ttm)

131.74M

Diluted EPS (ttm)

4.22

Quarterly earnings growth (yoy)

209.30%

Balance sheet

Total cash (mrq)

38.47M

Total cash per share (mrq)

1.24

Total debt (mrq)

940.81M

Total Debt/Equity (mrq)

100.85

Current ratio (mrq)

227.10%

Book value per share (mrq)

30.21

Cash flow

Cash flow statement

180.02M

Levered free cash flow (LFCF)

126.05M